021d1fa401df58eb6c374ed10d331b7fb98ba616
CD83.md
| ... | ... | @@ -1,7 +1,7 @@ |
| 1 | 1 | # CD83 |
| 2 | 2 | ## Overview |
| 3 | 3 | |
| 4 | -CD83 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. |
|
| 4 | +CD83 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. |
|
| 5 | 5 | |
| 6 | 6 | ## Relevance tier by entity |
| 7 | 7 | |
| ... | ... | @@ -39,7 +39,7 @@ CD83 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) |
| 39 | 39 | |chr6 |14118026 |14120025|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr6%3A14118026%2D14120025)|active_promoter-strong_enhancer| |
| 40 | 40 | |
| 41 | 41 | > [!NOTE] |
| 42 | -> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468). First described in DLBCL in 2013 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/23699601). First described in FL in 2023 by [Russler-Germain DA](https://pubmed.ncbi.nlm.nih.gov/37493986) |
|
| 42 | +> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468). First described in DLBCL in 2013.<sup>1</sup> First described in FL in 2023.<sup>2</sup> |
|
| 43 | 43 | |
| 44 | 44 | |
| 45 | 45 | View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CD83_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CD83_protein_hg38.html) |
| ... | ... | @@ -49,3 +49,7 @@ View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAM |
| 49 | 49 | View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CD83.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CD83_hg38.html) |
| 50 | 50 | |
| 51 | 51 |  |
| 52 | + |
|
| 53 | +## References |
|
| 54 | +1. *Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256-65. doi: 10.1182/blood-2013-02-483727. Epub 2013 May 22. PMID: 23699601; PMCID: PMC3744992.* |
|
| 55 | +2. *Russler-Germain DA, Krysiak K, Ramirez C, Mosior M, Watkins MP, Gomez F, Skidmore ZL, Trani L, Gao F, Geyer S, Cashen AF, Mehta-Shah N, Kahl BS, Bartlett NL, Alderuccio JP, Lossos IS, Ondrejka SL, Hsi ED, Martin P, Leonard JP, Griffith M, Griffith OL, Fehniger TA. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303. Blood Adv. 2023 Sep 26;7(18):5524-5539. doi: 10.1182/bloodadvances.2023010779. PMID: 37493986; PMCID: PMC10514406.* |
|
| ... | ... | \ No newline at end of file |